Search

ISSN: 2228-5881 eISSN: 2251-7308

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Indexing Info About APB & Contacts Indexing and Abstracting Articles In Press Archive

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308
pISSN: 2228-5881

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Powered by

Abstracting and Indexing

PubMed Central, Pubmed,

Emerging Sources Citation Index

Scopus, Google Scholar,

EMBASE/Excerpta Medica

EBSCOhost; CAS: DOAJ

SCImago Journal & Country Rank

2024, Vol 14, No. 4

Advanced Pharmaceutical Bulletin (APB) is a peer-reviewed multidisciplinary open access journal, covering a wide range of various integrative fields with Pharmaceutical sciences.
APB is the official journal of Drug Applied Research Center and Faculty of Pharmacy, published by TUOMS PRESS, Tabriz University of Medical Sciences.

Publication Advantages in Advanced Pharmaceutical Bulletin are:

Free of charge publication for all types of articles
Fast and constructive peer review
Easy and quick online submission of manuscripts
Author friendly review
Rapid publication by means of running issue concept, which gives authors the benefit of 'No Waiting Time' for the officially accepted manuscripts
Free publication of color images
Worldwide visibility of papers (Open Access Journal)

Perspective

1. New Approaches in Immunotherapy of Behçet Disease

Fatemeh Zare Shahneh, Mozhdeh Mohammadian, Zohreh Babaloo*, Behzad Baradaran

Adv Pharm Bull. 2013;3(1): 9-11. doi: 10.5681/apb.2013.002

PMCID: PMC3846049 PMID: 24312805 Scopus ID: 84874985397

Article

PDF

XML

Cited By:

6

6

Editorial

2. New Approaches to the Immunotherapy of Type 1 Diabetes Mellitus Using Interleukin-27

Fatemeh Zamani, Shohreh Almasi, Tohid Kazemi, Rana Jahanban Esfahlan, Mohammad Reza Aliparasti*

Adv Pharm Bull. 2015;5(5): 599-603. doi: 10.15171/apb.2015.081

PMCID: PMC4708029 PMID: 26793604 Scopus ID: 84954116938

Article

PDF

XML

Cited By:

4

1

7

Research Article

3. Acellular Wharton’s Jelly, Potentials in T-Cell Subtypes Differentiation, Activation and Proliferation

Mehdi Talebi , Hojjatollah Nozad Charoudeh, Ali Akbar Movassaghpour Akbari, Behzad Baradaran, Tohid Kazemi*

Adv Pharm Bull. 2020;10(4): 617-622. doi: 10.34172/apb.2020.074

PMCID: PMC7539310 PMID: 33072540 Scopus ID: 85090475597

Article

PDF

Full Text

XML

Cited By:

1

1

3

Research Article

4. The Beneficial Effects of Actinomycetales Immune Modulators in the Pancreas of Diabetic Rats

Monireh Khordadmehr* , Solin Ghaderi, Mehran Mesgari-Abbasi, Farinaz Jigari-Asl, Katayoon Nofouzi, Hossein Tayefi-Nasrabadi, Graham McIntyre

Adv Pharm Bull. 2021;11(2): 371-377. doi: 10.34172/apb.2021.035

PMCID: PMC8046390 PMID: 33880360 Scopus ID: 85103225799

Article

PDF

Full Text

XML

Cited By:

0

0

1

Review Article

5. CAR T Cells: Cancer Cell Surface Receptors Are the Target for Cancer Therapy

Behrouz Shademan , Vahidreza Karamad, Alireza Nourazarian, Cigir Biray Avcı*

Adv Pharm Bull. 2022;12(3): 476-489. doi: 10.34172/apb.2022.051

PMCID: PMC9348524 PMID: 35935042 Scopus ID: 85123831502

Article

PDF

Full Text

XML

Cited By:

1

2

4

Mini Review

6. Immunotherapy in Cancer Management: A Literature Review of Clinical Efficacy of Pembrolizumab in the Non-small Cell Lung Cancer Treatment

Luísa Biscaglia Miquelotti , Marcel Henrique Marcondes Sari , Luana Mota Ferreira*

Adv Pharm Bull. 2023;13(1): 88-95. doi: 10.34172/apb.2023.007

PMCID: PMC9871265 PMID: 36721805

Article

PDF

Full Text

XML

Cited By:

1

3